Toprol-XL is a brand name of metoprolol, approved by the FDA in the following formulation(s):
TOPROL-XL (metoprolol succinate - tablet, extended release; oral)
Manufacturer: ASTRAZENECA
Approval date: January 10, 1992
Strength(s): EQ 100MG TARTRATE [AB], EQ 200MG TARTRATE [RLD][AB], EQ 50MG TARTRATE [RLD][AB]
Manufacturer: ASTRAZENECA
Approval date: February 5, 2001
Strength(s): EQ 25MG TARTRATE [AB]
Has a generic version of Toprol-XL been approved?
A generic version of Toprol-XL has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Toprol-XL and have been approved by the FDA:
metoprolol succinate tablet, extended release; oral
Manufacturer: MYLAN PHARMS INC
Approval date: December 15, 2011
Strength(s): EQ 100MG TARTRATE [AB], EQ 200MG TARTRATE [AB], EQ 25MG TARTRATE [AB], EQ 50MG TARTRATE [AB]
Manufacturer: NESHER PHARMS
Approval date: May 18, 2007
Strength(s): EQ 100MG TARTRATE [AB], EQ 200MG TARTRATE [AB]
Manufacturer: NESHER PHARMS
Approval date: March 20, 2008
Strength(s): EQ 25MG TARTRATE [AB]
Manufacturer: NESHER PHARMS
Approval date: May 14, 2008
Strength(s): EQ 50MG TARTRATE [AB]
Manufacturer: SANDOZ
Approval date: July 31, 2006
Strength(s): EQ 25MG TARTRATE [AB]
Manufacturer: SANDOZ
Approval date: May 18, 2007
Strength(s): EQ 50MG TARTRATE [AB]
Manufacturer: SANDOZ
Approval date: March 20, 2008
Strength(s): EQ 100MG TARTRATE [AB], EQ 200MG TARTRATE [AB]
Manufacturer: WATSON LABS FLORIDA
Approval date: August 3, 2009
Strength(s): EQ 25MG TARTRATE [AB], EQ 50MG TARTRATE [AB]
Manufacturer: WATSON LABS FLORIDA
Approval date: April 15, 2010
Strength(s): EQ 100MG TARTRATE [AB], EQ 200MG TARTRATE [AB]
Manufacturer: WOCKHARDT
Approval date: July 22, 2010
Strength(s): EQ 100MG TARTRATE [AB], EQ 200MG TARTRATE [AB], EQ 25MG TARTRATE [AB], EQ 50MG TARTRATE [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Toprol-XL. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Toprol-XL.
Related Exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
- Exclusivity expiration dates:
- July 18, 2010 - REVISIONS TO LABELING BASED ON DATA SUBMITTED IN RESPONSE TO PEDIATRIC WRITTEN REQUEST
- January 18, 2011 - PEDIATRIC EXCLUSIVITY
See also...
- Toprol Consumer Information (Drugs.com)
- Toprol XL Extended-Release Tablets Consumer Information (Wolters Kluwer)
- Toprol-XL Consumer Information (Cerner Multum)
- Toprol XL Advanced Consumer Information (Micromedex)
- Metoprolol Consumer Information (Drugs.com)
- Metoprolol Succinate Extended-Release Tablets Consumer Information (Wolters Kluwer)
- Metoprolol Tartrate Consumer Information (Wolters Kluwer)
- Metoprolol Tartrate Tablets Consumer Information (Wolters Kluwer)
- Metoprolol Tartrate Consumer Information (Cerner Multum)
- Metoprolol Consumer Information (Cerner Multum)
- Metoprolol Advanced Consumer Information (Micromedex)
- Metoprolol Intravenous Advanced Consumer Information (Micromedex)
- Metoprolol Succinate AHFS DI Monographs (ASHP)
- Metoprolol Tartrate AHFS DI Monographs (ASHP)
No comments:
Post a Comment